Prognostic value of tumor-infiltrating lymphocyte subtypes in residual tumors of patients with triple-negative breast cancer after neoadjuvant chemotherapy

BACKGROUND: After neoadjuvant chemotherapy (NAC), non-pathological complete response of breast cancer patients can benefit from tailored adjuvant chemotherapy. However, it is difficult to select patients with poorer prognosis for additional adjuvant chemotherapy to maximize the benefits. Our study a...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Yu-Ge, Gao, Guo-Xuan, Zhang, Hong, Zhang, Shuang, Liu, Yin-Hua, Duan, Xue-Ning, Xu, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065871/
https://www.ncbi.nlm.nih.gov/pubmed/32044815
http://dx.doi.org/10.1097/CM9.0000000000000656

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065871/
https://www.ncbi.nlm.nih.gov/pubmed/32044815
http://dx.doi.org/10.1097/CM9.0000000000000656

Ejemplares similares